Large sample size and nonlinear sparse models outline epistatic effects in inflammatory bowel disease

Table 1 Benchmark of our NN architectures specifically designed for the WES-based case–control IBD prediction against conventional methods

^aPerformance given as mean (standard deviation) of test set ROC AUC from 10 different full threefold cross-validation runs with identical splits across models

ISSN: 1474-760X